About
Gameto is a women's health biotechnology company advancing programs from a cell engineering platform developed with George Church's lab at Harvard Medical School. Founded by Dr. Dina Radenkovic, a medical doctor-turned-entrepreneur, and Martin Varsavsky, founder of one of North America's largest fertility clinic network, Inception Prelude, Gameto has raised $127 million from leading investors to develop therapies that address fertility, menopause, and women's and family health. The company's lead program, Fertilo, is currently in Phase 3 clinical trials.